Johan Sjodahl
Chief Tech/Sci/R&D Officer bei ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
Profil
Johan Sjodahl is currently the Chief Scientific Officer at ISR Immune System Regulation Holding AB since 2021.
He has a graduate and doctorate degree from the Royal Institute of Technology.
Aktive Positionen von Johan Sjodahl
| Unternehmen | Position | Beginn |
|---|---|---|
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Chief Tech/Sci/R&D Officer | 01.01.2021 |
Ausbildung von Johan Sjodahl
| Royal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ISR Immune System Regulation Holding AB
 ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
